Clinical Trial Update: Quetiapine Extended Release (XR) for the Management of Psychotic Aggression or Agitation in Adult Acute Psychiatry [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating quetiapine extended-release for managing psychotic aggression or agitation in adults with schizophrenia or psychosis; the cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychosis
• Schizophrenia

Drugs mentioned

• Quetiapine XR (quetiapine)

Snippet

Sponsor: Bayside Health | Conditions: Schizophrenia, Psychosis | Phase 4 | Status: UNKNOWN